Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
May 2, 2012 goldberg murray a Officer Option Execute 54,438 21.92
May 1, 2012 aberman michael s Officer Automatic Sell 6,162 134.52 - 135.29
May 1, 2012 schleifer leonard s Officer Automatic Sell 100,000 133.86 - 136.57
May 1, 2012 yancopoulos george Officer Automatic Sell 33,165 133.95 - 135.29
Apr 30, 2012 aberman michael s Officer Automatic Sell 6,338 138.31
Apr 30, 2012 aberman michael s Officer Option Execute 12,500 24.00
Apr 30, 2012 van plew daniel p Officer Sell 14,442 135.94 - 136.42
Apr 27, 2012 van plew daniel p Officer Disposition (Non Open Market) 15,990 138.36
Apr 27, 2012 van plew daniel p Officer Option Execute 35,216 20.90
Apr 19, 2012 baker charles a Director Automatic Sell 12,910 125.00
Apr 19, 2012 baker charles a Director Option Execute 12,910 18.80
Apr 17, 2012 baker charles a Director Automatic Sell 2,090 125.00
Apr 17, 2012 baker charles a Director Option Execute 2,090 18.80
Mar 30, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,852 n/a
Mar 26, 2012 goldstein joseph l Director Automatic Sell 5,000 120.00
Mar 26, 2012 goldstein joseph l Director Option Execute 5,000 18.61
Mar 26, 2012 yancopoulos george Officer Automatic Sell 33,150 120.21 - 121.09
Mar 15, 2012 goldstein joseph l Director Automatic Sell 10,000 110.77 - 115.00
Mar 15, 2012 goldstein joseph l Director Option Execute 10,000 18.61
Mar 1, 2012 brown michael s Director Automatic Sell 20,000 102.65 - 104.32
Showing 401-420 of 834 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)